CDMO Sterling plots buyout of antibody-drug conjugate specialist in play at next-gen oncology market

CDMO Sterling plots buyout of antibody-drug conjugate specialist in play at next-gen oncology market
fkansteiner
Wed, 12/02/2020 – 10:25